News › Clinical Practice, Industry News, Patient Care

Restylane Brand Shares First-of-its-kind Phase IV Kissability Study Results

July 14, 2020

The Restylane brand has announced results of a first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, evaluating not only subject satisfaction, but also, for the first time, partner satisfaction following treatment with Restylane Kysse. Many consumers report they often keep their lip treatments a secret and have concerns about partner perceptions after injection. In the Kissability study, all subjects (100%) and a majority of their partners (90%) were satisfied with their lips after Restylane Kysse treatment, with most partners (73%) reporting a more kissable and natural feel.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available